BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32595022)

  • 1. Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging.
    Balaya V; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngô C; Le Frère-Belda MA; Mathevet P; Lécuru F
    Gynecol Oncol; 2020 Sep; 158(3):576-583. PubMed ID: 32595022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frozen section examination of sentinel lymph nodes can be used as a decisional tool in the surgical management of early cervical cancer.
    Rychlik A; Angeles MA; Migliorelli F; Croce S; Mery E; Martinez A; Ferron G; Guyon F; Querleu D
    Int J Gynecol Cancer; 2020 Mar; 30(3):358-363. PubMed ID: 31911532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carbon nanoparticle tracing of sentinel lymph nodes in diagnosis and treatment of cervical cancer and clinical value of lymph node ultrastaging detection].
    Lin X; He J; Lu J; Huang C; Liu N
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Dec; 42(12):1896-1901. PubMed ID: 36651260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard ultrastaging compared to one-step nucleic acid amplification (OSNA) for the detection of sentinel lymph node metastases in early stage cervical cancer.
    Santoro A; Angelico G; Inzani F; Arciuolo D; Spadola S; Valente M; D'Alessandris N; Piermattei A; Fiorentino V; CIanfrini F; Bizzarri N; Pedone Anchora L; Fagotti A; Scambia G; Zannoni GF
    Int J Gynecol Cancer; 2020 Dec; 30(12):1871-1877. PubMed ID: 33127865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Salvo G; Ramirez PT; Levenback CF; Munsell MF; Euscher ED; Soliman PT; Frumovitz M
    Gynecol Oncol; 2017 Apr; 145(1):96-101. PubMed ID: 28188015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial.
    Cibula D; Kocian R; Plaikner A; Jarkovsky J; Klat J; Zapardiel I; Pilka R; Torne A; Sehnal B; Ostojich M; Petiz A; Sanchez OA; Presl J; Buda A; Raspagliesi F; Kascak P; van Lonkhuijzen L; Barahona M; Minar L; Blecharz P; Pakiz M; Wydra D; Snyman LC; Zalewski K; Zorrero C; Havelka P; Redecha M; Vinnytska A; Vergote I; Tingulstad S; Michal M; Kipp B; Slama J; Marnitz S; Bajsova S; Hernandez A; Fischerova D; Nemejcova K; Kohler C
    Eur J Cancer; 2020 Sep; 137():69-80. PubMed ID: 32750501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node in cervical cancer: time to move forward.
    Balaya V; Guani B; Pache B; Durand YG; Bonsang-Kitzis H; Ngô C; Mathevet P; Lécuru F
    Chin Clin Oncol; 2021 Apr; 10(2):18. PubMed ID: 33951917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sentinel node technique detects unexpected drainage pathways and allows nodal ultrastaging in early cervical cancer: insights from the multicenter prospective SENTICOL study.
    Bats AS; Mathevet P; Buenerd A; Orliaguet I; Mery E; Zerdoud S; Le Frère-Belda MA; Froissart M; Querleu D; Martinez A; Leblanc E; Morice P; Daraï E; Marret H; Gillaizeau F; Lécuru F
    Ann Surg Oncol; 2013 Feb; 20(2):413-22. PubMed ID: 22911367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer.
    Balaya V; Bresset A; Guani B; Magaud L; Montero Macias R; Delomenie M; Bonsang-Kitzis H; Ngô C; Bats AS; Mathevet P; Lécuru F
    Gynecol Oncol; 2020 Jan; 156(1):93-99. PubMed ID: 31839343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accuracy of intraoperative frozen section examination of sentinel lymph nodes in squamous cell cancer of the vulva.
    Swift BE; Tigert M; Nica A; Covens A; Vicus D; Parra-Herran C; Kupets R; Osborne R; Gien LT
    Gynecol Oncol; 2022 Feb; 164(2):393-397. PubMed ID: 34893347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological factors associated with non-sentinel lymph node metastasis in early stage cervical cancer.
    Diniz TP; Faloppa CC; Mantoan H; Gonçalves BT; Kumagai LY; Menezes ANO; Badiglian-Filho L; Guimaraes APG; da Costa AABA; De Brot L; Baiocchi G
    J Surg Oncol; 2021 Mar; 123(4):1115-1120. PubMed ID: 33524165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative surgical algorithm: sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer.
    Balaya V; Bresset A; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngo C; Mathevet P; Lécuru F;
    Int J Gynecol Cancer; 2020 Sep; 30(9):1317-1325. PubMed ID: 32753560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the one-step nucleic acid amplification method for rapid detection of lymph node metastases in endometrial cancer: prospective, multicenter, comparative study.
    La Fera E; Bizzarri N; Petrecca A; Monterossi G; Dinoi G; Zannoni GF; Restaino S; Palmieri E; Mariuzzi L; Peters I; Scambia G; Fanfani F
    Int J Gynecol Cancer; 2023 Jul; 33(7):1063-1069. PubMed ID: 37105584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.
    Diaz JP; Gemignani ML; Pandit-Taskar N; Park KJ; Murray MP; Chi DS; Sonoda Y; Barakat RR; Abu-Rustum NR
    Gynecol Oncol; 2011 Mar; 120(3):347-52. PubMed ID: 21216450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node low-volume metastasis in early-stage cervical cancer.
    Bizzarri N; Pedone Anchora L; Zannoni GF; Santoro A; Valente M; Inzani F; Gallotta V; Conte C; Chiantera V; Fanfani F; Fagotti A; Ferrandina G; Scambia G
    Int J Gynecol Cancer; 2020 Mar; 30(3):364-371. PubMed ID: 31980488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of micrometastases in non-sentinel pelvic lymph nodes in cervical cancer.
    Cibula D; Zikan M; Slama J; Fischerova D; Kocian R; Germanova A; Burgetova A; Dusek L; Dundr P; Gregova M; Nemejcova K
    Gynecol Oncol; 2016 Oct; 143(1):83-86. PubMed ID: 27421753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors of unexpected lymphatic drainage pathways in early-stage cervical cancer.
    Balaya V; Mathevet P; Magaud L; Bonsang-Kitzis H; Delomenie M; Montero Macias R; Ngô C; Bats AS; Lécuru F
    Gynecol Oncol; 2019 Jul; 154(1):102-109. PubMed ID: 31003746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer.
    Lago V; Montero B; López S; Padilla-Iserte P; Matute L; Marina T; Gurrea M; Montoliu G; Bello P; Domingo S
    Gynecol Oncol; 2021 May; 161(2):408-413. PubMed ID: 33712275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer.
    Slama J; Dundr P; Dusek L; Cibula D
    Gynecol Oncol; 2013 May; 129(2):384-8. PubMed ID: 23395889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.